Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: A propensity-matched study of the EPHESUS trial

International Journal of Cardiology

Volumn 143, Issue 3, 2010, Pages 309-316

  Pitt, Bertram ^a   Zannad, Faiez ^b   Gheorghiade, Mihai ^c   Martínez, Felipe ^d   Love, Thomas E ^e   Daniel, Casey ^g   Ahmed, Ali ^f,g  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITÉ DE LORRAINE   (France)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Hospitalization; Mortality; Post AMI; Propensity score; Transatlantic variations

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; LOOP DIURETIC AGENT; NITRATE; STATIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLOOD CLOT LYSIS; CAUSE OF DEATH; CORONARY ARTERY BYPASS GRAFT; EUROPE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PRIORITY JOURNAL;

EUROPE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; NORTH AMERICA; OUTCOME ASSESSMENT (HEALTH CARE); PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77956614599     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.036     Document Type: Article

References (16)

1. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
2. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
3. M.A. Pfeffer, J.J. McMurray, and E.J. Velazquez Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med. 349 2003 1893 1906
4. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
5. P.R. Rosenbaum, and D.B. Rubin The central role of propensity score in observational studies for causal effects Biometrika 70 1983 41 55
6. D.B. Rubin Using propensity score to help design observational studies: application to the tobacco litigation Health Serv. Outcomes Res. Method. 2 2001 169 188
7. A. Ahmed, A. Husain, and T.E. Love Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods Eur Heart J 27 2006 1431 1439
8. A. Ahmed, F. Zannad, and T.E. Love A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure Eur Heart J 28 2007 1334 1343
9. A. Ahmed, M.W. Rich, and P.W. Sanders Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study Am J Cardiol 99 2007 393 398
10. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
11. S.T. Normand, M.B. Landrum, and E. Guadagnoli Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores J Clin Epidemiol 54 2001 387 398
12. SPSS for Windows, Rel. 15 program]. SPSS Inc., Chicago, IL; 2008.
13. J.E. Blair, F. Zannad, and M.A. Konstam Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program J Am Coll Cardiol 52 2008 1640 1648
14. AstraZeneca LP. Toprol-XL® (metoprolol succinate) Tablets Prescribing Information. Södertälje, Sweden. http://www1.astrazeneca-us.com/pi/ toprol-xl.pdf ; 2007.
15. G. Fitzmaurice Confounding: regression adjustment Nutrition 22 2006 581 583
16. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150